Atlas Trials

Effect of Enzalutamide Dose Reduction on Fatigue, Cognition, and Drug Trough Levels in Patients With Prostate Cancer

Clinical trial NCT03124615 · UNKNOWN

Trial details

NCT number
NCT03124615
Sponsor
Macquarie University, Australia
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2017-05-01
Primary completion
2020-12-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.